EARLY-ONSET MYASTHENIA-GRAVIS - CLINICAL CHARACTERISTICS AND RESPONSE TO THERAPY

被引:43
|
作者
BATOCCHI, AP [1 ]
EVOLI, A [1 ]
PALMISANI, MT [1 ]
LOMONACO, M [1 ]
BARTOCCIONI, M [1 ]
TONALI, P [1 ]
机构
[1] UNIV CATTOLICA SACRO CUORE, INST GEN PATHOL, I-00168 ROME, ITALY
关键词
corticosteroids; Myasthenia gravis; Thymectomy;
D O I
10.1007/BF01959485
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We studied 59 children with myasthenia gravis (MG). Disease onset was pre-pubertal in 26 patients and post-pubertal in 33. The male to female ratio was 0.62 in the early- and 0.17 in the late-onset groups. The frequency of ocular MG was higher in patients with prepubertal onset. Patients with generalized MG generally showed a good response to thymectomy and corticosteroid therapy proved effective with no major side-effects. In our experience early-onset MG has the same course as in adult life. We recommend thymectomy for generalized disease in childhood, except in very young children on account of possible long-term effects on immunological development. Immunosuppressive therapy should be considered in severely affected patients who do not respond adequately to other therapies. © 1990 Springer-Verlag.
引用
收藏
页码:66 / 68
页数:3
相关论文
共 50 条
  • [1] Case Series: Clinical Impact of Plasmapheresis and Thymectomy on Early-Onset Myasthenia Gravis
    Siahaan, Yusak M. T.
    Ketaren, Retno Jayantri
    Pangestu, Aristo Rinaldi
    Hartoyo, Vinson
    CASE REPORTS IN NEUROLOGY, 2021, 13 (01) : 1 - 8
  • [2] Late onset forms of myasthenia gravis.: Comparison with early-onset myasthenia gravis.
    Barbaud, A.
    Carlander, B.
    Pages, M.
    REVUE NEUROLOGIQUE, 2006, 162 (10) : 990 - 996
  • [3] IMMUNOPHARMACOLOGICAL THERAPY IN MYASTHENIA-GRAVIS
    SHAH, A
    LISAK, RP
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 (02) : 97 - 103
  • [4] RESPONSE TO THYMECTOMY IN CHINESE PATIENTS WITH MYASTHENIA-GRAVIS
    KAY, R
    LAM, S
    WONG, KS
    WANG, A
    HO, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 126 (01) : 84 - 87
  • [5] Late-onset non-thymomatous myasthenia gravis: Comparison with early-onset and very late-onset myasthenia gravis
    Cho, Eun Bin
    Min, Ju-Hong
    Lee, Sujin
    Yoon, Cindy W.
    Seok, Jin Myoung
    Cho, Hye-Jin
    Lee, Hye Lim
    Kim, Byoung Joon
    NEUROLOGY ASIA, 2017, 22 (02) : 123 - 131
  • [6] HLA-DPB1 POLYMORPHISMS IN PATIENTS WITH HYPERTHYROID GRAVES-DISEASE AND EARLY-ONSET MYASTHENIA-GRAVIS
    RATANACHAIYAVONG, S
    FLEMING, D
    JANER, M
    DEMAINE, AG
    WILLCOX, N
    NEWSOMDAVIS, J
    MCGREGOR, AM
    AUTOIMMUNITY, 1994, 17 (02) : 99 - 104
  • [7] Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
    Lee, Myung Ah
    Lee, Chonghwee
    Park, Jung Hyun
    Lee, Jung Hwan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (10)
  • [8] Clinical characteristics of late-onset myasthenia gravis
    Sun, Chenjing
    Ren, Zhuangzhuang
    Miao, Xiuling
    Zheng, Yanxu
    Zhang, Jun
    Qi, Xiaokun
    Liu, Jianguo
    Qiu, Feng
    HELIYON, 2024, 10 (07)
  • [9] Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies
    Romi, F
    Gilhus, NE
    Varhaug, JE
    Myking, A
    Aarli, JA
    EUROPEAN NEUROLOGY, 2003, 49 (04) : 210 - 217
  • [10] TITIN ANTIBODIES IN PATIENTS WITH LATE-ONSET MYASTHENIA-GRAVIS - CLINICAL CORRELATIONS
    SKEIE, GO
    MYGLAND, A
    AARLI, JA
    GILHUS, NE
    AUTOIMMUNITY, 1995, 20 (02) : 99 - 104